NANT CANCER VACCINE
Live / Registered — Registered (as of 03 Sept 2024)
What this means for you
Registered since 03 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97599709
- Registration number
- 7491160
- Mark type
- Stylized text
- Filed
- 20 Sept 2022
- Published for opposition
- 18 Jun 2024
- Registered
- 03 Sept 2024
- Attorney of record
- Michael J. McCue
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, vaccine preparations; low-dose chemotherapeutics, low dose radiopharmaceutical preparations, and personalized neoepitope-targeted pharmaceutical preparations for medical use for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biological preparations, namely, cell-derived preparations, cell therapeutics, monoclonal antibodies, cytokines, immune modulators, low-dose chemotherapeutics, low-dose radiation therapeutics, antibodies, fusion proteins, peptide and cytokine biological preparations, vaccines, personalized neoepitope-based therapeutics, and natural killer cell derived preparations, for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, autoimmune diseases, infectious diseases, animal diseases, and cancer for clinical, medicinal, therapeutic, and veterinary purposes; kits comprising cell cultures, reagents and related instructions, for use in the treatment and prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, autoimmune diseases, infectious diseases, animal diseases and cancer, for clinical, medicinal, therapeutic and veterinary purposes
Owner
- Nant Holdings IP, LLC, Culver City, CA, US
- Nant Holdings IP, LLC, Culver City, CA, US
- Nant Holdings IP, LLC, Culver City, CA, US
Prior registrations
Prosecution history
- 03 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 18 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jun 2024 — PUBLISHED FOR OPPOSITION
- 29 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 May 2024 — EXAMINER'S AMENDMENT ENTERED
- 14 May 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 May 2024 — EXAMINERS AMENDMENT E-MAILED
- 14 May 2024 — EXAMINERS AMENDMENT -WRITTEN
- 15 Feb 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 15 Feb 2024 — FINAL REFUSAL E-MAILED
- 15 Feb 2024 — FINAL REFUSAL WRITTEN
- 21 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE